Log in to your Inderes Free account to see all free content on this page.
FluoGuide
48.3 SEK -6.03%HC Andersen Capital has previously received payment from FluoGuide for a Digital IR/Corporate Visibility agreement. This means that there may be paid material that is not updated. See disclaimer.
5 investors are following this company
FluoGuide is a Danish company active in medical technology. The company's business focus is found in research and development of treatments against various forms of cancer, with the greatest focus on the development of products that guide surgical interventions. The products bind to the cancer cells, which then light up and are intended to be used to precisely remove harmful tumors in the patient's tissue.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
FLUO
Daily low / high price
47.8 / 51
SEK
Market cap
589.66M SEK
Turnover
64.49K SEK
Volume
1.3K
Latest videos
Financial calendar
Interim report
30.05.2024
Interim report
29.08.2024
Interim report
28.11.2024
Annual report
27.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Life Science IVS | 17.7 % | 17.7 % |
Wexotec ApS | 12.4 % | 12.4 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Minutes from Annual General Meeting in FluoGuide A/S
HCA Biosnack update: Biotech and Life Science stocks outperform as the general stock market moves to record highs.
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio